1 Medical Research Council, Clinical Research Centre, Watford Road, Harrow, Middlesex, England and Royal Hospital for Sick Children, Sciennes Road, Edinburgh, Scotland
Pregnanetriol was not excreted by an infant (7 days old) who was later shown to have a defect in steroid 21-hydroxylase. However, the excretion of this compound increased during the following days (1.2 mg on the thirteenth day of life). A high excretion of 3
-hydroxy-
steroids was the most noticeable abnormality in steroid excretion noted on the seventh day of life (e.g., 3
, 16
-dihydroxy-5-pregnen-20-one, 15 mg; 3
, 21-dihydroxy-5-pregnen-20-one, 1.4 mg and 3
, 16
-dihydroxy-5-androsten-17-one, 7.4 mg). This high 3
-hydroxy-
steroid excretion results in difficulties in distinguishing a defect in 3
-hydroxy steroid dehydrogenase from a 21-hydroxylase deficiency.
At the age of 14 months the principal steroids excreted were those predominant in other cases of 21-hydroxylase deficiency, viz. pregnanetriol and 5
-pregnane-3
, 17
, 20
-triol-11-one (11-oxo-pregnanetriol).
This article has been cited by other articles:
![]() |
N Ikekawa, Y Fujimoto, M Isiguro, S Suwa, Y Hirayama, and H Mizunuma C26 sterol in a human urine Science, June 15, 1979; 204(4398): 1223 - 1224. [Abstract] [PDF] |
||||